# Efficacy and Safety of Cytoflavin® Used in Elderly Patients for the Prevention of Cognitive Decline After Major Surgery

> **NCT03849664** · PHASE3 · COMPLETED · sponsor: **POLYSAN Scientific & Technological Pharmaceutical Company** · enrollment: 200 (actual)

## Conditions studied

- Cognitive Dysfunction

## Interventions

- **DRUG:** Cytoflavin® solution
- **DRUG:** Cytoflavin® enteric-coated tablet
- **DRUG:** Placebo solution
- **DRUG:** Placebo enteric-coated tablet

## Key facts

- **NCT ID:** NCT03849664
- **Lead sponsor:** POLYSAN Scientific & Technological Pharmaceutical Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-06-02
- **Primary completion:** 2019-04-11
- **Final completion:** 2019-07-11
- **Target enrollment:** 200 (ACTUAL)
- **Last updated:** 2023-01-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03849664

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03849664, "Efficacy and Safety of Cytoflavin® Used in Elderly Patients for the Prevention of Cognitive Decline After Major Surgery". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03849664. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*